Unknown

Dataset Information

0

Targeted Elimination of Tumorigenic Human Pluripotent Stem Cells Using Suicide-Inducing Virus-like Particles.


ABSTRACT: Sensitization to prodrugs via transgenic expression of suicide genes is a leading strategy for the selective elimination of potentially tumorigenic human pluripotent stem cells (hPSCs) in regenerative medicine, but transgenic modification poses safety risks such as deleterious mutagenesis. We describe here an alternative method of delivering suicide-inducing molecules explicitly to hPSCs using virus-like particles (VLPs) and demonstrate its use in eliminating undifferentiated hPSCs in vitro. VLPs were engineered from Q? bacteriophage capsids to contain enhanced green fluorescent protein (EGFP) or cytosine deaminase (CD) and to simultaneously display multiple IgG-binding ZZ domains. After labeling with antibodies against the hPSC-specific surface glycan SSEA-5, EGFP-containing particles were shown to specifically bind undifferentiated cells in culture, and CD-containing particles were able to eliminate undifferentiated hPSCs with virtually no cytotoxicity to differentiated cells upon treatment with the prodrug 5-fluorocytosine.

SUBMITTER: Rampoldi A 

PROVIDER: S-EPMC6343126 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeted Elimination of Tumorigenic Human Pluripotent Stem Cells Using Suicide-Inducing Virus-like Particles.

Rampoldi Antonio A   Crooke Stephen N SN   Preininger Marcela K MK   Jha Rajneesh R   Maxwell Joshua J   Ding Lingmei L   Spearman Paul P   Finn M G MG   Xu Chunhui C  

ACS chemical biology 20180719 8


Sensitization to prodrugs via transgenic expression of suicide genes is a leading strategy for the selective elimination of potentially tumorigenic human pluripotent stem cells (hPSCs) in regenerative medicine, but transgenic modification poses safety risks such as deleterious mutagenesis. We describe here an alternative method of delivering suicide-inducing molecules explicitly to hPSCs using virus-like particles (VLPs) and demonstrate its use in eliminating undifferentiated hPSCs in vitro. VLP  ...[more]

Similar Datasets

| S-EPMC4437484 | biostudies-literature
| S-EPMC4291089 | biostudies-other
| S-EPMC6102287 | biostudies-literature
| S-EPMC4817893 | biostudies-other
| S-EPMC3289320 | biostudies-literature
| S-EPMC4301813 | biostudies-literature
| S-EPMC3499526 | biostudies-literature
| S-EPMC3138859 | biostudies-literature
| S-EPMC3921628 | biostudies-literature
| S-EPMC3728319 | biostudies-literature